Cidara Therapeutics Inc.

NASDAQ: CDTX · Real-Time Price · USD
64.85
1.30 (2.05%)
At close: Aug 15, 2025, 3:05 PM

Cidara Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.01 -3.03 -1.57 -1.57
PEG Ratio
-0.00 0.07 0.04 0.03
PS Ratio
133.87 1.09 0.82 1.34
PB Ratio
1.05 -8.46 -18.2 3.09
P/FCF Ratio
-0.97 -3.03 -1.85 -2.63
P/OCF Ratio
-0.97 -3.09 -1.86 -2.64
OCF/S Ratio
-138.46 -0.35 -0.44 -0.51
Debt / Equity Ratio
0.02 -0.59 -0.42 0.23
Quick Ratio
4.25 0.81 1.09 2.18
Current Ratio
4.25 0.90 1.09 2.11
Asset Turnover
0.01 0.95 1.35 0.66
Interest Coverage
n/a n/a n/a -199.32
Return on Equity
-1.04 2.79 11.56 -1.97
Return on Assets
-0.79 -0.34 -0.71 -0.56
Return on Invested Capital
-1.04 -27.37 -3.94 -0.97
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-65.57 0.98 1.00 1.00
Net Profit Margin
-133.2 -0.36 -0.52 -0.86
Pretax Profit Margin
-133.56 -0.35 -0.34 -0.86
Operating Profit Margin
-138.12 -0.38 -0.52 -0.85
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-138.12 -0.38 -0.52 -0.85